Greenwich LifeSciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 Apr 24 | BuyUS$57,240 | Snehal Patel | Individual | 3,000 | US$19.08 | |
22 Mar 24 | BuyUS$49,950 | Snehal Patel | Individual | 2,500 | US$19.98 | |
20 Mar 24 | BuyUS$26,520 | Snehal Patel | Individual | 1,500 | US$17.68 | |
05 Mar 24 | BuyUS$43,715 | Snehal Patel | Individual | 3,500 | US$12.49 | |
04 Mar 24 | BuyUS$53,423 | Snehal Patel | Individual | 4,100 | US$13.03 | |
16 Feb 24 | BuyUS$120,528 | Snehal Patel | Individual | 10,800 | US$11.16 | |
15 Feb 24 | BuyUS$140,589 | Snehal Patel | Individual | 12,700 | US$11.07 | |
10 Nov 23 | BuyUS$50,838 | Snehal Patel | Individual | 5,000 | US$10.17 | |
03 Nov 23 | BuyUS$31,885 | Snehal Patel | Individual | 3,500 | US$9.11 | |
27 Oct 23 | BuyUS$4,285 | Jaye Thompson | Individual | 500 | US$8.57 | |
26 Oct 23 | BuyUS$19,925 | Snehal Patel | Individual | 2,500 | US$7.97 | |
25 Oct 23 | BuyUS$19,775 | Snehal Patel | Individual | 2,500 | US$7.91 | |
10 Oct 23 | BuyUS$9,070 | Snehal Patel | Individual | 1,000 | US$9.07 | |
04 Oct 23 | BuyUS$17,260 | Snehal Patel | Individual | 2,000 | US$8.63 | |
26 Sep 23 | BuyUS$5,226 | Jaye Thompson | Individual | 600 | US$8.71 | |
19 Sep 23 | BuyUS$35,800 | Snehal Patel | Individual | 4,000 | US$8.95 | |
11 Sep 23 | BuyUS$9,480 | Snehal Patel | Individual | 1,000 | US$9.48 | |
22 Aug 23 | BuyUS$9,970 | Snehal Patel | Individual | 1,000 | US$9.97 | |
04 Aug 23 | BuyUS$21,100 | Snehal Patel | Individual | 2,000 | US$10.55 | |
21 Jul 23 | BuyUS$9,200 | Snehal Patel | Individual | 1,000 | US$9.20 | |
13 Jul 23 | BuyUS$2,373 | Jaye Thompson | Individual | 250 | US$9.49 | |
17 May 23 | BuyUS$11,690 | Snehal Patel | Individual | 1,000 | US$11.69 |
Insider Trading Volume
Insider Buying: GLSI insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 1,436 | 0.0112% |
Institutions | 623,427 | 4.84% |
General Public | 5,221,373 | 40.5% |
Individual Insiders | 7,032,173 | 54.6% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
5,350,777 | US$74.2m | 0.72% | no data | |||
620,327 | US$8.6m | 0% | no data | |||
397,333 | US$5.5m | 0% | no data | |||
313,255 | US$4.3m | 0% | no data | |||
260,348 | US$3.6m | 0.19% | no data | |||
221,682 | US$3.1m | 0.79% | no data | |||
90,133 | US$1.3m | 0% | no data | |||
87,000 | US$1.2m | 0% | 1.65% | |||
57,148 | US$792.6k | 2.07% | no data | |||
53,647 | US$744.1k | -15.4% | no data | |||
46,816 | US$649.3k | 1.57% | no data | |||
36,600 | US$507.6k | -32.6% | no data | |||
20,983 | US$291.0k | 0% | no data | |||
19,604 | US$271.9k | 0% | 0.02% | |||
14,714 | US$204.1k | 1,020% | no data | |||
14,005 | US$194.3k | 0% | no data | |||
13,002 | US$180.3k | 0% | no data | |||
11,511 | US$159.7k | -39.9% | no data | |||
9,524 | US$132.1k | 0% | no data | |||
5,578 | US$77.4k | 139,000% | no data | |||
4,842 | US$67.2k | 43.7% | no data | |||
1,840 | US$25.5k | 184,000% | no data | |||
1,500 | US$20.8k | 0% | 0.01% | |||
1,436 | US$19.9k | 10.8% | no data | |||
1,138 | US$15.8k | 0% | no data |